Learn More
Medchemexpress LLC QL-X-138 | 1469988-63-3 | 99.8% | 421.45 | C25H19N5O2 | 1MG

Supplier: Medchemexpress LLC HY1246451MG
QL-X-138 is a small-molecule BTK/MNK dual kinase inhibitor that covalently binds to BTK and non-covalently to MNK. It is provided as a high-purity solid for laboratory research and has been characterized in preclinical studies for activity against hematologic malignancies and dengue virus.
- Dual inhibition of Bruton tyrosine kinase (BTK) and MAPK-interacting kinase (MNK).
- Covalent binding to BTK and non-covalent binding to MNK.
- High-purity solid form suitable for laboratory research.
- Molecular formula C25H19N5O2 and molecular weight 421.45.
- Demonstrated preclinical activity in models of lymphoma, leukemia, and dengue virus.
- For research use only; not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.